Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Pharmaceutical composition for preventing liver cirrhosis and its application

A composition and drug technology, applied in the field of medicine, can solve the problems of preventing the occurrence of liver cirrhosis, and achieve the effects of preventing diffuse fibrous hyperplasia in the liver, preventing the formation of liver pseudolobules, and stabilizing quality control

Inactive Publication Date: 2016-12-07
THE FIRST AFFILIATED HOSPITAL OF XINXIANG MEDICAL UNIV
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] At present, there is no better drug to prevent the occurrence and development of liver cirrhosis

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pharmaceutical composition for preventing liver cirrhosis and its application
  • Pharmaceutical composition for preventing liver cirrhosis and its application
  • Pharmaceutical composition for preventing liver cirrhosis and its application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025] A pharmaceutical composition for preventing liver cirrhosis. The pharmaceutical composition comprises the following raw materials prepared according to parts by weight: 1 part of 8-hydroxyradixin, 8 parts of 6-hydroxydendrobine, white and dihydrophenanthrene 10 parts of pyranol, 7 parts of pokeweed saponin A and 3 parts of pinoxinone.

Embodiment 2

[0027] A pharmaceutical composition for preventing liver cirrhosis. The pharmaceutical composition comprises the following raw materials formulated in parts by weight: 100 parts of 8-hydroxyradixanthin, 100 parts of 6-hydroxydendrobine, white and dihydrophenanthrene 100 parts of pyranol, 100 parts of pokeweed saponin A and 100 parts of pinoxinone.

Embodiment 3

[0029] A pharmaceutical composition for preventing liver cirrhosis. The pharmaceutical composition comprises the following raw materials formulated in parts by weight: 50.5 parts of 8-hydroxyradixin, 54 parts of 6-hydroxydendrobine, white and dihydrophenanthrene 55 parts of pyranol, 53.5 parts of pokeweed saponin A and 51.5 parts of pinoxinone.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for preventing liver cirrhosis and its application; the pharmaceutical composition is prepared from the following raw materials: 8-hydroxyradixin, 6-hydroxydendrobine, Dihydrophenanthrenopyranol, pokeweed saponin A and pinocinone; it has the advantages of effectively preventing liver cirrhosis with obvious effect, stable quality control and suitable for long-term use by patients.

Description

technical field [0001] The invention belongs to the technical field of medicine, and in particular relates to a pharmaceutical composition for preventing liver cirrhosis and its application. Background technique [0002] Liver cirrhosis (hepatic cirrhosis) is diffuse liver damage caused by one or more causes of long-term or repeated effects, with fibrous tissue hyperplasia as the main manifestation, and belongs to chronic progressive liver disease. The main cause of cirrhosis is hepatitis, and a small part is alcoholic cirrhosis and schistosome cirrhosis. Tissue biopsy found extensive liver cell necrosis, nodular regeneration of liver cells, hyperplasia of connective tissue and formation of fibrous septa in patients with liver cirrhosis, leading to structural destruction of liver lobules and formation of pseudolobules, causing the liver to gradually deform and harden, and eventually develop into hepatic lobule. hardening. Patients with liver cirrhosis may have no obvious s...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/58A61P1/16A61K31/568A61K31/357A61K31/421
Inventor 段树鹏李爱辉刘艳伟常晋玲朱利红杨静黄宁李嘉李鹏
Owner THE FIRST AFFILIATED HOSPITAL OF XINXIANG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com